Search research articles
Contact Us
Filters
Showing results (41-50 of 67) with videos related to
Page
of 7
Sort By:
Cancers
|
December 26, 2018
Interplay between Epigenetics, Expression of Estrogen Receptor- α, HER2/ERBB2 and Sensitivity of Triple Negative Breast Cancer Cells to Hormonal Therapy
Wafaa S Ramadan, Cijo George Vazhappilly, Ekram M Saleh, et al.
Current Medicinal Chemistry
|
February 16, 2013
Tandem multicomponent reactions toward the design and synthesis of novel antibacterial and cytotoxic motifs
Mohammad H Semreen, Raafat El-Awady, Raed Abu-Odeh, et al.
Bioorganic Chemistry
|
August 12, 2025
Further insights into the multitarget anticancer activity of tetrahydrocarbazole-1-amine/5-arylidene-4-thiazolinone based hybrids
Basma S Ali, Anber F Mohammed, Varsha Menon, et al.
Cancer Genomics & Proteomics
|
December 24, 2021
Untargeted Metabolomics of Breast Cancer Cells MCF-7 and SkBr3 Treated With Tamoxifen/Trastuzumab
Basma M Sharaf, Alexander D Giddey, Hasan Alniss, et al.
Investigational New Drugs
|
June 28, 2018
Inhibition of SHP2 by new compounds induces differential effects on RAS/RAF/ERK and PI3K/AKT pathways in different cancer cell types
Cijo George Vazhappilly, Ekram Saleh, Wafaa Ramadan, et al.
Biochemical Pharmacology
|
November 10, 2025
Opposing outcomes of short- and long-term epigenetic therapy in breast cancer: Implications for chemotherapy response
Wafaa S Ramadan, Varsha Menon, Ragheb Alsheikh Zein, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
August 31, 2020
Induction of DNA damage, apoptosis and cell cycle perturbation mediate cytotoxic activity of new 5-aminosalicylate-4-thiazolinone hybrid derivatives
Wafaa S Ramadan, Ekram M Saleh, Varsha Menon, et al.
Cancer Chemotherapy and Pharmacology
|
October 20, 2022
Mass spectroscopy-based proteomics and metabolomics analysis of triple-positive breast cancer cells treated with tamoxifen and/or trastuzumab
Basma M Sharaf, Alexander D Giddey, Hamza M Al-Hroub, et al.
Chemical Biology & Drug Design
|
January 26, 2025
N-Substituted-5- [(2,5-Dihydroxybenzyl)amino]salicylamides as Lavendustin Analogs: Antiproliferative Activity, COMPARE Analyses, Mechanistic, Docking, ADMET and Toxicity Studies
Hajjaj H M Abdu-Allah, Mohamed K S El-Nagar, Wesam S Qayed, et al.
Bioorganic Chemistry
|
July 31, 2024
Transcriptomic analysis of MCF7 breast cancer cells treated with MGBs reveals a profound inhibition of estrogen receptor genes
Hasan Y Alniss, Maha M Saber-Ayad, Wafaa S Ramadan, et al.
Page
of 7
Search research articles
Search
Showing results (41-50 of 67) with videos related to
Sort By:
Page
of 7
Cancers
|
December 26, 2018
Interplay between Epigenetics, Expression of Estrogen Receptor- α, HER2/ERBB2 and Sensitivity of Triple Negative Breast Cancer Cells to Hormonal Therapy
Wafaa S Ramadan, Cijo George Vazhappilly, Ekram M Saleh, et al.
Current Medicinal Chemistry
|
February 16, 2013
Tandem multicomponent reactions toward the design and synthesis of novel antibacterial and cytotoxic motifs
Mohammad H Semreen, Raafat El-Awady, Raed Abu-Odeh, et al.
Bioorganic Chemistry
|
August 12, 2025
Further insights into the multitarget anticancer activity of tetrahydrocarbazole-1-amine/5-arylidene-4-thiazolinone based hybrids
Basma S Ali, Anber F Mohammed, Varsha Menon, et al.
Cancer Genomics & Proteomics
|
December 24, 2021
Untargeted Metabolomics of Breast Cancer Cells MCF-7 and SkBr3 Treated With Tamoxifen/Trastuzumab
Basma M Sharaf, Alexander D Giddey, Hasan Alniss, et al.
Investigational New Drugs
|
June 28, 2018
Inhibition of SHP2 by new compounds induces differential effects on RAS/RAF/ERK and PI3K/AKT pathways in different cancer cell types
Cijo George Vazhappilly, Ekram Saleh, Wafaa Ramadan, et al.
Biochemical Pharmacology
|
November 10, 2025
Opposing outcomes of short- and long-term epigenetic therapy in breast cancer: Implications for chemotherapy response
Wafaa S Ramadan, Varsha Menon, Ragheb Alsheikh Zein, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
August 31, 2020
Induction of DNA damage, apoptosis and cell cycle perturbation mediate cytotoxic activity of new 5-aminosalicylate-4-thiazolinone hybrid derivatives
Wafaa S Ramadan, Ekram M Saleh, Varsha Menon, et al.
Cancer Chemotherapy and Pharmacology
|
October 20, 2022
Mass spectroscopy-based proteomics and metabolomics analysis of triple-positive breast cancer cells treated with tamoxifen and/or trastuzumab
Basma M Sharaf, Alexander D Giddey, Hamza M Al-Hroub, et al.
Chemical Biology & Drug Design
|
January 26, 2025
N-Substituted-5- [(2,5-Dihydroxybenzyl)amino]salicylamides as Lavendustin Analogs: Antiproliferative Activity, COMPARE Analyses, Mechanistic, Docking, ADMET and Toxicity Studies
Hajjaj H M Abdu-Allah, Mohamed K S El-Nagar, Wesam S Qayed, et al.
Bioorganic Chemistry
|
July 31, 2024
Transcriptomic analysis of MCF7 breast cancer cells treated with MGBs reveals a profound inhibition of estrogen receptor genes
Hasan Y Alniss, Maha M Saber-Ayad, Wafaa S Ramadan, et al.
Page
of 7